Fidelity International
UTHR icon

Fidelity International’s United Therapeutics UTHR Stock Holding History

Fidelity International’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
3,021
-9,430
-76% -$4.7M ﹤0.01% 785
2025
Q4 		$6.07M Buy
12,451
+11,699
+1,556% +$5.45M ﹤0.01% 634
2025
Q3 		$315K Buy
+752
New +$253K ﹤0.01% 848
2024
Q4 		– Sell
-1,231
Closed -$441K – 980
2024
Q3 		$441K Buy
+1,231
New +$416K ﹤0.01% 784
2020
Q4 		– Sell
-112
Closed -$11K – 1084
2020
Q3 		$11K Hold
112
– – ﹤0.01% 746
2020
Q2 		$14K Hold
112
– – ﹤0.01% 725
2020
Q1 		$11K Hold
112
– – ﹤0.01% 701
2019
Q4 		$10K Hold
112
– – ﹤0.01% 749
2019
Q3 		$9K Hold
112
– – ﹤0.01% 710
2019
Q2 		$9K Hold
112
– – ﹤0.01% 716
2019
Q1 		$13K Sell
112
-460,716
-100% -$53.7M ﹤0.01% 686
2018
Q4 		$50.2M Sell
460,828
-6,319
-1% -$733K 0.09% 217
2018
Q3 		$59.7M Buy
467,147
+3,032
+0.7% +$375K 0.09% 231
2018
Q2 		$52.5M Sell
464,115
-179,332
-28% -$19.7M 0.08% 255
2018
Q1 		$72.3M Buy
643,447
+1,772
+0.3% +$225K 0.2% 134
2017
Q4 		$94.9M Buy
641,675
+163,633
+34% +$20.8M 0.26% 103
2017
Q3 		$56M Buy
+478,042
New +$61M 0.16% 142

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity International's UTHR Position: Q1 2026 in Review

Fidelity International reduced its United Therapeutics (UTHR) stake by 76% in Q1 2026, selling an estimated $4.7M and leaving 3,021 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Fidelity International first reported a position in UTHR in Q3 2017 and has held it in 17 quarters since. The position peaked at $94.9M in Q4 2017. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Fidelity International held 3,021 shares of United Therapeutics worth $1.79M as of Q1 2026.
  • Fidelity International sold 9,430 United Therapeutics shares in Q1 2026, an estimated $4.7M.
  • United Therapeutics made up ﹤0.01% of Fidelity International's portfolio in Q1 2026, its #785 holding.
  • Fidelity International first reported a position in United Therapeutics in Q3 2017 and has held it in 17 quarters since.
  • Fidelity International's United Therapeutics position peaked at $94.9M in Q4 2017.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.